catalog number : 
MBS125846
products full name : 
SNCA Polyclonal Antibody
products short name : 
SNCA
products name syn : 
alpha-Synuclein: a-Synuclein; TLR7-like
other names : 
Alpha-synuclein; Alpha-synuclein; alpha-synuclein; synuclein alpha-140; non A-beta component of AD amyloid; synuclein, alpha (non A4 component of amyloid precursor); Non-A beta component of AD amyloid; Non-A4 component of amyloid precursor; NACP
products gene name : 
SNCA
other gene names : 
SNCA; SNCA; PD1; NACP; PARK1; PARK4; NACP; PARK1; NACP
uniprot entry name : 
SYUA_HUMAN
reactivity : 
Human, Mouse, Rat
purity : 
Affinity Purification
storage stability : 
Store at -20 degree C (regular) or -80 degree C (long term). Avoid freeze / thaw cycles.  Buffer: PBS with 0.02% sodium azide, 50% glycerol, pH7.3.
tested application : 
Western Blot (WB), Immunohistochemistry (IHC)
app notes : 
WB: 1:200 - 1:2000. IHC: 1:50 - 1:200
other info1 : 
Species: Human.  Route: Recombinant Protein
other info2 : 
Immunogen: Fusion protein of human SNCA.  Calculated Molecular Weight: 14kDa
products categories : 
Polyclonal
products description : 
SNCA, also named as NACP, PARK1 and Alpha-synuclein, belongs to the synuclein family. It may be involved in the regulation of dopamine release and transport. SNCA reduces neuronal responsiveness to various apoptotic stimuli, leading to a decreased caspase-3 activation. The deposition of aggregated SNCa is the pathological hallmark of Lewy body disease, which includes Parkinson's disease (PD), diffuse Lewy body disease (DLBD), and Lewy body variant of Alzheimer's disease (LBV).(PMID:21056999) This antibody can recognize all the isoforms of SNCA.
ncbi pathways : 
Alpha-synuclein Signaling Pathway  137913!!Alzheimer's Disease Pathway  83097!!Alzheimer's Disease Pathway  509!!Alzheimers Disease Pathway  672448!!Amyloids Pathway  366238!!Disease Pathway  530764!!EGFR1 Signaling Pathway  198782!!Parkin-Ubiquitin Proteasomal System Pathway  700638!!Parkinson's Disease Pathway  83098!!Parkinsons Disease Pathway  705377
ncbi summary : 
Alpha-synuclein is a member of the synuclein family, which also includes beta- and gamma-synuclein. Synucleins are abundantly expressed in the brain and alpha- and beta-synuclein inhibit phospholipase D2 selectively. SNCA may serve to integrate presynaptic signaling and membrane trafficking. Defects in SNCA have been implicated in the pathogenesis of Parkinson disease. SNCA peptides are a major component of amyloid plaques in the brains of patients with Alzheimer's disease. Four alternatively spliced transcripts encoding two different isoforms have been identified for this gene. [provided by RefSeq, Mar 2009]